APA (7th ed.) Citation

Wu, S., Wang, Y., Deng, D., Zheng, G., Mei, H., Wang, C., . . . Xiang, M. (2025). Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy. Natural Products & Bioprospecting, 15(1), 1. https://doi.org/10.1007/s13659-025-00540-9

Chicago Style (17th ed.) Citation

Wu, Songtao, et al. "Dual Inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis Chinensis Unveils a Metabolic Checkpoint for Liver Cancer Therapy." Natural Products & Bioprospecting 15, no. 1 (2025): 1. https://doi.org/10.1007/s13659-025-00540-9.

MLA (9th ed.) Citation

Wu, Songtao, et al. "Dual Inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis Chinensis Unveils a Metabolic Checkpoint for Liver Cancer Therapy." Natural Products & Bioprospecting, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1007/s13659-025-00540-9.